UPDATE: The chart below was updated in June 2020. Revisions to the R35 program are allowable to address special research priorities, e.g. COVID-19.
Since supplemental grant funding comes in a variety of flavors, with different purposes, it’s not surprising that there’s confusion about which kinds of supplements MIRA grantees may apply for and which they may not. Here’s a quick run-down.
Type of Supplement
Links to NIH Guide
|Revisions (Formerly known as Competitive Supplements)||PAR-17-190
For Early Stage Investigator MIRA
For Established Investigator MIRA
|Revisions are not an allowed application type in the R35 FOAs except to address special research priorities, e.g., COVID-19.|
|Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Announcement under which administrative supplement requests must be made)||PA-18-591||Unless otherwise noted NIGMS will only accept administrative supplement requests to fund equipment or to address special research priorities, e.g., Alzheimer’s research. (See below.)|
|Equipment supplements||NOT-GM-19-013||Eligible to apply|
|Administrative Supplements to Address Special Research Priorities, e.g., Alzheimer’s||NOT-AG-18-039||Supplement must be for work that falls outside the NIGMS mission and therefore, if successful, would not in the future be funded by NIGMS. This type of supplement generally allows MIRA grantees to explore possible applications of their research to clinical or other areas not funded by NIGMS.|
|Diversity supplements||PA-18-906||Eligible to apply|
|Re-entry supplements||PA-18-592||Eligible to apply|
We strongly encourage you to contact your program director before applying for any supplement.